Ryo Nakagomi

1.4k total citations · 1 hit paper
24 papers, 788 citations indexed

About

Ryo Nakagomi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ryo Nakagomi has authored 24 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 19 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Ryo Nakagomi's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Hepatitis C virus research (9 papers). Ryo Nakagomi is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Hepatitis C virus research (9 papers). Ryo Nakagomi collaborates with scholars based in Japan and Germany. Ryo Nakagomi's co-authors include Kazuhiko Koike, Tatsuya Minami, Hayato Nakagawa, Masaya Sato, Ryosuke Tateishi, Kenichiro Enooku, Koji Uchino, Naoto Fujiwara, Yoshinari Asaoka and Shuichiro Shiina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Ryo Nakagomi

23 papers receiving 783 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma

2015 544 citations Naoto Fujiwara, Hayato Nakagawa et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryo Nakagomi Japan	10	405	324	321	183	141	24	788
Hideki Miyata Japan	13	167 0.4×	280 0.9×	285 0.9×	141 0.8×	115 0.8×	37	584
Toine M. Lodewick Netherlands	13	229 0.6×	142 0.4×	95 0.3×	141 0.8×	168 1.2×	25	477
Ninos Ayez Netherlands	12	348 0.9×	280 0.9×	48 0.1×	446 2.4×	325 2.3×	19	841
Nobuaki Azemoto Japan	15	118 0.3×	419 1.3×	404 1.3×	187 1.0×	228 1.6×	32	703
Nicola de Liguori Carino United Kingdom	15	76 0.2×	196 0.6×	190 0.6×	327 1.8×	306 2.2×	43	665
Gabriella Pittau France	18	126 0.3×	675 2.1×	320 1.0×	278 1.5×	711 5.0×	73	1.1k
Hiromitsu Maehira Japan	13	45 0.1×	79 0.2×	102 0.3×	275 1.5×	244 1.7×	83	522
Martin Gaillard France	14	101 0.2×	213 0.7×	117 0.4×	98 0.5×	415 2.9×	64	615
Seung Bae Yoon South Korea	17	158 0.4×	12 0.0×	135 0.4×	319 1.7×	514 3.6×	71	852
Marianne Latournerie France	15	35 0.1×	202 0.6×	151 0.5×	158 0.9×	230 1.6×	42	631

Countries citing papers authored by Ryo Nakagomi

Since Specialization

Citations

This map shows the geographic impact of Ryo Nakagomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Nakagomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Nakagomi more than expected).

Fields of papers citing papers by Ryo Nakagomi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Nakagomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Nakagomi. The network helps show where Ryo Nakagomi may publish in the future.

Co-authorship network of co-authors of Ryo Nakagomi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Nakagomi. A scholar is included among the top collaborators of Ryo Nakagomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Nakagomi. Ryo Nakagomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakatsuka, T., Ryo Nakagomi, Tomoharu Yamada, et al.. (2025). Pre‐Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication. Hepatology Research. 56(2). 161–171. 1 indexed citations

Okushin, Kazuya, Ryosuke Tateishi, Hisateru Tachimori, et al.. (2024). The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL). Scientific Reports. 14(1). 2826–2826. 2 indexed citations

Sato, Masaya, Makoto Moriyama, Tsuyoshi Fukumoto, et al.. (2023). Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation. Hepatology International. 18(1). 131–137. 9 indexed citations

Nakatsuka, T., Hayato Nakagawa, Koji Uchino, et al.. (2023). Clinical utility of postablation liver tumor biopsy and possibility of gene mutation analysis. Hepatology Research. 53(11). 1117–1125.

Fukumoto, Tsuyoshi, Tatsuya Minami, Makoto Moriyama, et al.. (2022). Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals. Hepatology Communications. 6(9). 2496–2512. 4 indexed citations

Sato, Masaya, Ryosuke Tateishi, Makoto Moriyama, et al.. (2022). Machine Learning–Based Personalized Prediction of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation. SHILAP Revista de lepidopterología. 1(1). 29–37. 6 indexed citations

Okushin, Kazuya, Ryosuke Tateishi, Arata Takahashi, et al.. (2022). Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL). Journal of Gastroenterology. 57(8). 587–597. 7 indexed citations

Sekino, Yuta, Ryosuke Tateishi, Nobuyoshi Fukumitsu, et al.. (2022). Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis. Liver Cancer. 12(4). 297–308. 5 indexed citations

Nakatsuka, T., Hayato Nakagawa, Yuki Hayata, et al.. (2021). Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma. Journal of Gastroenterology. 56(5). 456–469. 19 indexed citations

10.

Uchino, Koji, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2021). Radiofrequency Ablation of Liver Tumors in Patients on Antithrombotic Therapy: A Case-Control Analysis of over 10,000 Treatments. Journal of Vascular and Interventional Radiology. 32(6). 869–877. 2 indexed citations

11.

Hayata, Yuki, Hayato Nakagawa, Satoshi Kawamura, et al.. (2021). Axin2+ Peribiliary Glands in the Periampullary Region Generate Biliary Epithelial Stem Cells That Give Rise to Ampullary Carcinoma. Gastroenterology. 160(6). 2133–2148.e6. 18 indexed citations

12.

Nakagomi, Ryo, Ryosuke Tateishi, Shintaro Mikami, et al.. (2021). Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics. PLoS ONE. 16(11). e0259641–e0259641. 3 indexed citations

13.

Tateishi, Ryosuke, Tsuyoshi Fukumoto, Ryo Nakagomi, et al.. (2020). Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volume. PLoS ONE. 15(4). e0231836–e0231836. 4 indexed citations

14.

Minami, Tatsuya, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2018). Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy. Journal of Hepatology. 70(1). 78–86. 62 indexed citations

15.

Uchino, Koji, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2018). Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation. PLoS ONE. 13(7). e0200943–e0200943. 4 indexed citations

16.

Minami, Tatsuya, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2015). Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients. Medicine. 94(23). e901–e901. 11 indexed citations

17.

Fujiwara, Naoto, Hayato Nakagawa, Yotaro Kudo, et al.. (2015). Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. Journal of Hepatology. 63(1). 131–140. 544 indexed citations breakdown →

18.

Minami, Tatsuya, Ryosuke Tateishi, Shuichiro Shiina, et al.. (2015). Comparison of improved prognosis between hepatitis B‐ and hepatitis C‐related hepatocellular carcinoma. Hepatology Research. 45(10). E99–E107. 13 indexed citations

19.

Nakagawa, Hayato, Naoto Fujiwara, Ryosuke Tateishi, et al.. (2014). Impact of serum levels of interleukin‐6 and adiponectin on all‐cause, liver‐related, and liver‐unrelated mortality in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. 30(2). 379–388. 19 indexed citations

20.

Takagi, M., et al.. (2003). Design and synthesis of oatp subtype-specific antisense oligonucleotides having 2'-O,4'-C-ethylene-bridged nucleic acids (ENATM). Nucleic Acids Symposium Series. 3(1). 83–84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact